FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W4200572807> ?p ?o ?g. }

• W4200572807 endingPage "4381" @default.
• W4200572807 startingPage "4381" @default.
• W4200572807 abstract "Astaxanthin (ASTX) is an antioxidant agent. Recently, its use has been focused on the prevention of diabetes and atherosclerosis. We examined the effects of astaxanthin supplementation for 12 weeks on glucose metabolism, glycemic control, insulin sensitivity, lipid profiles and anthropometric indices in healthy volunteers including subjects with prediabetes with a randomized, placebo-controlled trial.We enrolled 53 subjects who met our inclusion criteria and administered them with 12 mg astaxanthin or a placebo once daily for 12 weeks. Subsequently, their HbA1c levels, lipid profiles and biochemical parameters were determined. The participants also underwent a 75 g oral glucose tolerance test (OGTT), vascular endothelial function test and measurement of the visceral fat area.After astaxanthin supplementation for 12 weeks, glucose levels after 120 min in a 75 g OGTT significantly decreased compared to those before supplementation. Furthermore, the levels of HbA1c (5.64 ± 0.33 vs. 5.57 ± 0.39%, p < 0.05), apo E (4.43 ± 1.29 vs. 4.13 ± 1.24 mg/dL, p < 0.05) and malondialdehyde-modified low-density lipoprotein (87.3 ± 28.6 vs. 76.3 ± 24.6 U/L, p < 0.05) were also reduced, whereas total cholesterol (TC), triglyceride (TG) and high-density lipoprotein-C (HDL-C) levels were unaltered. The Matuda index, which is one of the parameters of insulin resistance, was improved in the ASTX group compared to that before supplementation.our results suggest that ASTX may have preventive effects against diabetes and atherosclerosis and may be a novel complementary treatment option for the prevention of diabetes in healthy volunteers, including subjects with prediabetes, without adverse effects." @default.
• W4200572807 created "2021-12-31" @default.
• W4200572807 creator A5010235104 @default.
• W4200572807 creator A5016446325 @default.
• W4200572807 creator A5043379889 @default.
• W4200572807 creator A5055296923 @default.
• W4200572807 creator A5063101048 @default.
• W4200572807 creator A5064033751 @default.
• W4200572807 creator A5067429052 @default.
• W4200572807 creator A5079064213 @default.
• W4200572807 date "2021-12-07" @default.
• W4200572807 modified "2023-10-10" @default.
• W4200572807 title "The Beneficial Effects of Astaxanthin on Glucose Metabolism and Modified Low-Density Lipoprotein in Healthy Volunteers and Subjects with Prediabetes" @default.
• W4200572807 cites W1565527343 @default.
• W4200572807 cites W1974005731 @default.
• W4200572807 cites W1975686505 @default.
• W4200572807 cites W1975751846 @default.
• W4200572807 cites W1984920777 @default.
• W4200572807 cites W2010698039 @default.
• W4200572807 cites W2038894827 @default.
• W4200572807 cites W2049756201 @default.
• W4200572807 cites W2076314669 @default.
• W4200572807 cites W2085953034 @default.
• W4200572807 cites W2089370698 @default.
• W4200572807 cites W2089476892 @default.
• W4200572807 cites W2098373036 @default.
• W4200572807 cites W2098430882 @default.
• W4200572807 cites W2121654587 @default.
• W4200572807 cites W2134668199 @default.
• W4200572807 cites W2159248911 @default.
• W4200572807 cites W2403940369 @default.
• W4200572807 cites W2475954707 @default.
• W4200572807 cites W2767767370 @default.
• W4200572807 cites W2791011305 @default.
• W4200572807 doi "https://doi.org/10.3390/nu13124381" @default.
• W4200572807 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/34959932" @default.
• W4200572807 hasPublicationYear "2021" @default.
• W4200572807 type Work @default.
• W4200572807 citedByCount "8" @default.
• W4200572807 countsByYear W42005728072022 @default.
• W4200572807 countsByYear W42005728072023 @default.
• W4200572807 crossrefType "journal-article" @default.
• W4200572807 hasAuthorship W4200572807A5010235104 @default.
• W4200572807 hasAuthorship W4200572807A5016446325 @default.
• W4200572807 hasAuthorship W4200572807A5043379889 @default.
• W4200572807 hasAuthorship W4200572807A5055296923 @default.
• W4200572807 hasAuthorship W4200572807A5063101048 @default.
• W4200572807 hasAuthorship W4200572807A5064033751 @default.
• W4200572807 hasAuthorship W4200572807A5067429052 @default.
• W4200572807 hasAuthorship W4200572807A5079064213 @default.
• W4200572807 hasBestOaLocation W42005728071 @default.
• W4200572807 hasConcept C126322002 @default.
• W4200572807 hasConcept C134018914 @default.
• W4200572807 hasConcept C142724271 @default.
• W4200572807 hasConcept C185592680 @default.
• W4200572807 hasConcept C204787440 @default.
• W4200572807 hasConcept C27081682 @default.
• W4200572807 hasConcept C2776652674 @default.
• W4200572807 hasConcept C2777180221 @default.
• W4200572807 hasConcept C2777391703 @default.
• W4200572807 hasConcept C2778163477 @default.
• W4200572807 hasConcept C2778270857 @default.
• W4200572807 hasConcept C2778913445 @default.
• W4200572807 hasConcept C2779668308 @default.
• W4200572807 hasConcept C2780072125 @default.
• W4200572807 hasConcept C2780473172 @default.
• W4200572807 hasConcept C2780541478 @default.
• W4200572807 hasConcept C2780962900 @default.
• W4200572807 hasConcept C28781525 @default.
• W4200572807 hasConcept C55493867 @default.
• W4200572807 hasConcept C555293320 @default.
• W4200572807 hasConcept C71924100 @default.
• W4200572807 hasConceptScore W4200572807C126322002 @default.
• W4200572807 hasConceptScore W4200572807C134018914 @default.
• W4200572807 hasConceptScore W4200572807C142724271 @default.
• W4200572807 hasConceptScore W4200572807C185592680 @default.
• W4200572807 hasConceptScore W4200572807C204787440 @default.
• W4200572807 hasConceptScore W4200572807C27081682 @default.
• W4200572807 hasConceptScore W4200572807C2776652674 @default.
• W4200572807 hasConceptScore W4200572807C2777180221 @default.
• W4200572807 hasConceptScore W4200572807C2777391703 @default.
• W4200572807 hasConceptScore W4200572807C2778163477 @default.
• W4200572807 hasConceptScore W4200572807C2778270857 @default.
• W4200572807 hasConceptScore W4200572807C2778913445 @default.
• W4200572807 hasConceptScore W4200572807C2779668308 @default.
• W4200572807 hasConceptScore W4200572807C2780072125 @default.
• W4200572807 hasConceptScore W4200572807C2780473172 @default.
• W4200572807 hasConceptScore W4200572807C2780541478 @default.
• W4200572807 hasConceptScore W4200572807C2780962900 @default.
• W4200572807 hasConceptScore W4200572807C28781525 @default.
• W4200572807 hasConceptScore W4200572807C55493867 @default.
• W4200572807 hasConceptScore W4200572807C555293320 @default.
• W4200572807 hasConceptScore W4200572807C71924100 @default.
• W4200572807 hasIssue "12" @default.
• W4200572807 hasLocation W42005728071 @default.
• W4200572807 hasLocation W42005728072 @default.
• W4200572807 hasLocation W42005728073 @default.
• W4200572807 hasLocation W42005728074 @default.

• next